Skip to main content

Table 3 Proportion of patients on statin medication in each study group over time; n = 513

From: Successful implementation of best medical treatment for patients with asymptomatic carotid artery stenosis within a randomized controlled trial (SPACE-2)

Visit CEA CAS BMT total p1 p2
Screening 80.3% (163) 73.6% (145) 78.8% (89) 77.4% (397) 0.257  
D30 87.6% (163) 86.7% (156) 91.5% (97) 88.1% (416) 0.456  < 0.0001^*
M6 91.7% (166) 86.9% (152) 93.5% (101) 90.3% (419) 0.131  < 0.0001^*
A1 92.5% (160) 87.6% (149) 93.2% (96) 90.8% (405) 0.190  < 0.0001^*
  1. *Significant
  2. Chi2-test
  3. ^McNemar test
  4. Already published [23]; D30: Visit 30 days after screening visit; M6: Visit 6 months after screening visit; A1: Visit o ne year after screening visit
  5. 1testing CEA vs. CAS vs. BMT
  6. 2testing rate of statin medication on D30/M6/A1 vs. screening visit